Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 8Gynecologic 7Breast 6Genitourinary 5Gastrointestinal 5Sarcoma 3Other solid neoplasm 3Other hematologic neoplasm 3Lymphoid 3Head & Neck 3Tumor-Agnostic 1Plasma cell 1Other 1Endocrine 1Dermatologic 1

Conditions

Neoplasms, Plasma Cell 1Lymphoma 1

Interventions

Dexamethasone 870Lenalidomide 456Bortezomib 454Cyclophosphamide 365Melphalan 271Calcium Dobesilate 262daratumumab 233pomalidomide 207carfilzomib 182fludarabine phosphate 140fludarabine 136Thalidomide 125Peripheral Blood Stem Cell Transplantation 119Filgrastim 114ixazomib 93Mycophenolic Acid 90Granulocyte Colony-Stimulating Factor 89Whole-Body Irradiation 87Busulfan 87dexamethasone acetate 86Tacrolimus 78dexamethasone 21-phosphate 74Cyclosporine 68isatuximab 67auricularum 67Prednisone 65elotuzumab 58belantamab mafodotin 56Antilymphocyte Serum 56Etoposide 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Restraint, Physical × Plasma cell × Clear all
NCT04194840 2025-08-05

Transplant Wellness Clinic for Elderly or High Risk Patients Undergoing BMT

Case Comprehensive Cancer Center

Phase NA Completed
20 enrolled
LymphoidPlasma cell

Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡